share_log

Supernus Pharmaceuticals | 8-K: Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

SEC ·  Feb 27 16:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more